fasudil has been researched along with Osteonecrosis in 1 studies
fasudil: intracellular calcium antagonist; structure in first source
fasudil : An isoquinoline substituted by a (1,4-diazepan-1-yl)sulfonyl group at position 5. It is a Rho-kinase inhibitor and its hydrochloride hydrate form is approved for the treatment of cerebral vasospasm and cerebral ischemia.
Osteonecrosis: Death of a bone or part of a bone, either atraumatic or posttraumatic.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ikemura, S | 1 |
| Yamamoto, T | 1 |
| Motomura, G | 1 |
| Yamaguchi, R | 1 |
| Zhao, G | 1 |
| Iwasaki, K | 1 |
| Iwamoto, Y | 1 |
1 other study available for fasudil and Osteonecrosis
| Article | Year |
|---|---|
Preventive effects of the anti-vasospasm agent via the regulation of the Rho-kinase pathway on the development of steroid-induced osteonecrosis in rabbits.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adrenal Cortex Hormones; Animals; Male; Methylprednis | 2013 |